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Introduction
Every year, 15 million people worldwide have a stroke, leav-
ing 5 million people with a permanent disability.1 In 2012, 
6.7 million people worldwide died from stroke.2 In Australia, 
stroke is a leading cause of long-term adult disability3 with 
around 12,000 stroke deaths recorded in 2012.4 In the United 
States, there are 795,000 strokes every year.5 Ischaemic 
stroke is estimated to cost $140,048 over a lifetime with pro-
jections of direct medical stroke-related costs increasing from 
US$71.6 billion in 2012 to US$184.1 billion in 2030.6 In the 
United Kingdom, there are 100,000 strokes every year with 
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Abstract
Background: Intravenous thrombolysis is one of few evidence-based treatments for acute stroke. Treatment uptake is low 
outside major stroke care centres. There is a need for greater understanding of barriers encountered by clinicians when 
seeking to increase thrombolysis rates.
Aim: The aim of this study is to describe physicians’ and nurses’ perceptions regarding thrombolysis for acute stroke at 
hospitals in the earlier stages of thrombolysis implementation.
Methods: A cross-sectional paper survey completed by physicians’ and nurses’ was distributed to 1127 staff at stroke care 
units, emergency departments or equivalent stroke care facilities at 19 Australian hospitals, as part of a cluster randomised 
controlled trial for thrombolysis implementation and systems improvement.
Results: Of 1127 potential participants, 503 (148 physicians and 355 nurses) completed surveys (45% response rate). 
Over 90% agreed that thrombolysis improved the odds of independent survival. However, 42% to 58% agreed that there 
were limitations in the evidence base. A small proportion of staff indicated deficits in technical competencies. Interactive or 
competency-based training was reported by less than two-thirds of the sample. Challenges such as quick bed availability were 
identified. Emergency department physicians were less positive towards the treatment compared with nurses (p < 0.001), 
stroke care unit physicians were more positive than nurses (p = 0.047) and older clinicians were more positive than younger 
clinicians (p = 0.007).
Conclusion: Australian hospitals seeking to address barriers to stroke thrombolysis implementation may benefit from the 
availability of interactive and competency-based training, staff performance feedback, support to make beds available quickly 
and bypass arrangements to quickly deliver acute stroke patients to appropriate facilities.
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40,000 people dying from their stroke and 65% of survivors 
leaving the hospital with a disability.7 The annual National 
Health System and social care cost for stroke in the United 
Kingdom is around £1.7 billion.7 The majority of stroke 
cases are admitted to hospital8 with more than 35,000 stroke 
hospitalisations recorded in Australia in 2009 to 2010.9 
Intravenous (IV) tissue plasminogen activator (tPA) treat-
ment administered to eligible ischaemic stroke patients within 
4.5 h of onset is one of few evidence-based treatments for 
stroke in the acute phase.1,10
Appropriately administered thrombolysis treatment has 
proven to be cost-effective.11,12 The benefits of stroke throm-
bolysis treatment within 4.5 h of stroke onset have been 
endorsed by the United Kingdom’s Commission on Human 
Medicines,13 and tPA is supported by national and interna-
tional guidelines.14–18 The Model of Resource Utilization, 
Costs and Outcomes for Stroke study reports savings of 155 
disability adjusted life-years12 in a group of 256 eligible 
stroke patients, with an Australian study reporting savings of 
0.02 life-years and 0.04 quality-adjusted life-years per per-
son over a 1-year time period post treatment.19 Despite its 
benefits, tPA administration rates remain relatively low:20 
3.4% in the United States,21 11.4% in the United Kingdom22 
and 7% in Australia.22
Several barriers to the implementation of thrombolysis 
for acute stroke have been identified in the literature.23–26 
Pre-hospital barriers include lack of community knowl-
edge about stroke, stroke sufferers calling a primary care 
physician (rather than ambulance), mode of transport to 
hospital, failure to seek help urgently,27 and admission to a 
non-academic hospital.28 Bunch et al.29 reported that the 
main barrier to tPA treatment for in-hospital strokes is the 
delay in stroke recognition by staff. A systematic review 
by Kwan et al.23 highlights inefficient processes for emer-
gency stroke care and delays in obtaining treatment con-
sent. At a hospital level, increasing the use of IV tPA 
treatment is possible30 but requires multiple practice 
changes. Grol and Wensing’s31 theoretical model under-
pinned the survey.
The Individual health care provider factors are a signifi-
cant determinant of low tPA treatment rates.23 A common 
barrier is the inappropriate triage of patients by emergency 
and ambulance.23–25 Physicians’ uncertainty of the impact 
and administration of thrombolysis, familiarity with and 
motivation to adhere to recommended guidelines, are barri-
ers to treatment uptake.26 Scott et al.32 report that character-
istics associated with favourable clinician attitudes towards 
tPA included non-emergency medicine board certification, 
older age and a smaller hospital environment. Several stud-
ies reveal inefficient in-hospital processes for managing 
emergency stroke patients,23,24 lack of appropriate infrastruc-
ture, staffing and hospital capacity.24 The National Stroke 
Audit Report 2017 found that 25% of stroke patients do not 
have access to thrombolysis and 75% had an established 
stroke care unit (SCU).33 Cadilhac et al.34 reported that SCU 
access varied significantly in Australia with 3% access 
reported in rural areas versus 77% in metropolitan areas.
While existing data provide an indication of barriers faced 
by hospitals, a more focussed perspective and targeted efforts 
are needed to improve tPA use. This study primarily aims to 
explore barriers and facilitators to change among Australian 
hospitals in their early stages of stroke thrombolysis imple-
mentation, and to explore the association between the pro-
portion of patients thrombolysed at each hospital and the 
attitude of staff towards IV stroke thrombolysis.
The primary aim of this study is to: 
(a) Describe physicians’ and nurses’ perceptions regard-
ing key barriers and facilitators to increased tPA use 
within their hospital.
The secondary aims of this study are to:
(b) Describe characteristics associated with positive atti-
tudes towards tPA treatment.
(c) Assess the association between the actual proportion 
of patients thrombolysed at each hospital and average 
staff score on staff attitude towards tPA treatment.
Method
The study was approved by Human Research Ethics 
Committees in New South Wales, Victoria and Queensland. 
Implied consent was obtained from each participant by 
reading the Information Statement accompanying the staff 
survey and then completing and submitting the anonymous 
survey.
Study design
A cross-sectional survey was used to assess staff attitudes, 
personal characteristics and hospital characteristics associ-
ated with stroke thrombolysis.35
Participants
The survey was distributed to staff involved in either assess-
ment or treatment of potential stroke patients at 19 Australian 
hospitals enrolled in a cluster randomised controlled trial.36 
Metropolitan, regional, public and private hospitals in their 
early stages of stroke thrombolysis, with an ED (emergency 
department) and an SCU or equivalent capacity, were eligi-
ble to participate. All selected hospitals met the requirements 
for providing thrombolysis (trained staff, clinical facilities), 
and all but one had already provided thrombolysis treatment 
to stroke patients. Hospitals were selected from National 
Stroke Foundation audit records and state-based clinical 
SCU networks. Eligible staff were physicians and nurses 
who worked in the SCU, the ED or equivalent capacities and 
were rostered to work during the 1-month survey period.
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Procedure
Prior to survey distribution, agreement was reached with 
the site coordinator regarding which staff were eligible to 
participate based on providing either assessment of potential 
stroke, further assessment of suspected stroke patients or 
delivery of thrombolysis. The anonymous pen-and-paper 
survey was distributed in 2012 to 2013 prior to implementa-
tion of the trial intervention. It was distributed by a stroke 
clinician or stroke nurse at each hospital. A record was kept 
regarding the estimated number of eligible staff (e.g. emer-
gency and stroke unit doctors and nurses rostered to work 
during the survey month), surveys distributed and surveys 
returned. The timing of the data collection was dependent on 
staff availability to distribute and collect surveys for 1 month 
during a 12-month window (mid-2012 to mid-2013).
Measures
Staff survey. Surveys were modified from a previous survey 
developed by Grady et al. for ED staff37 and pilot-tested for 
readability, clarity and comprehensiveness of survey items 
by a team of behavioural researchers (n = 5), stroke clinicians 
(n = 2), ED physicians (n = 2) and stroke nurses (n = 2) at the 
University of Newcastle and Hunter New England Local 
Health District. The survey assessed thrombolysis practices, 
hospital characteristics, personal characteristics, individual 
provider context, social professional context and health sys-
tem context.
Attitudinal items were developed from literature regard-
ing knowledge implementation31 and a prior survey.35,37 
Respondents were asked to rate agreement with a series of 
statements. Participants were asked to rate their level of 
agreement with each survey item using a four-point scale of 
‘strongly disagree’, ‘disagree’, ‘agree’ and ‘strongly agree’ 
with a ‘not applicable’ option. Three versions were created 
allowing tailoring of items to the roles of SCU physicians, 
ED physicians and nurses.
The Individual health care provider context involved skills 
and experiences, including five items common to all provid-
ers, two nurse-only items and seven physician-only items, 
and attitudes towards thrombolysis. The Professional social 
context included leader opinions and practices and the pres-
ence of innovators, and workplace culture. The Health system 
context addressed hospital-level policies and practices.
In addition, Personal characteristics included principal 
role, gender, age group and years of experience in emergency 
and/or stroke care.
Survey scoring. The categories of strongly agree/agree were 
collapsed for all scoring as were the strongly disagree/disa-
gree categories. Where an item was positively framed, 
responses of ‘strongly agree’ or ‘agree’ were given a score 
of 1 and all remaining responses a score of 0. Reverse scor-
ing was used for negatively framed items. ‘Not applicable’ 
responses were excluded from the analysis. Domain scores 
were calculated for the domains of individual provider 
context, social context and health system context. Eight atti-
tudinal items were used to create an attitude score by sum-
ming the number of positive responses. A higher score 
indicated a more positive attitude towards tPA. Factor anal-
ysis and internal consistency of the survey items were calcu-
lated and are reported in the results.
Hospital-level data. Categorisation of hospitals as metropoli-
tan versus non-metropolitan was based on the classification 
used by available online health department information.
Statistical methods
Participant characteristics (profession specific and com-
bined) are presented as frequencies and percentages for cat-
egorical variables, and means and standard deviations for 
continuous variables.
The primary aim is to descriptive statistics including fre-
quencies and proportions were produced to desribe physi-
cians’ and nurses’ perceptions regarding key barriers and 
facilitators to increased use of tPA within their hospital. The 
secondary aims re as follows. (a) Multivariable linear regres-
sion was used to explore characteristics associated with atti-
tudinal items (within the individual provider context) 
towards tPA treatment. Coefficient estimates are presented 
with 95% Wald confidence intervals (CIs). The p values 
resulting from F tests are also presented for each variable in 
the model. No variable selection methods were used. 
Referent categories for the nominal variables are listed in the 
tables. (b) To assess the association between the proportion 
of patients receiving thrombolysis at each hospital and the 
average staff attitude score towards tPA treatment, case data 
were obtained from the study database and hospital 
International Classification of Diseases-10 reports over the 
baseline data collection period, to determine what proportion 
of stroke patients received thrombolysis at each hospital.
All statistical analyses used SAS, version 9.4 (SAS 
Institute, Cary, NC, USA). All participant responses were 
included in the analyses regardless of whether they agreed 
with the clinical evidence regarding thrombolysis in order to 
retain a complete picture of the perceptions of all relevant 
staff. We estimated for the worst-case scenario regarding 
prevalence of any one item being 50%, a sample size of 384 
would give a precision of ±5% with an alpha = 0.05.
Results
Response rate and participant characteristics
A total of 503 out of 1127 potential participants from 19 hos-
pitals completed the surveys (45% response rate). The 
response rate was 67% for SCU physicians (85/126), 32% 
for ED physicians (63/194) and 44% for nurses (355/807). 
Hospital response rates varied from 16% to 100% (Table 1). 
The sample contained both metropolitan and regional 
hospitals.
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Perceptions regarding individual, professional and 
health system contexts
Individual health care provider context and attitudes to acute 
stroke care. Physicians’ and nurses’ reported skills and 
experiences are listed in Table 2, including nurse-specific 
and physician-specific items. The mean domain score for 
the common items was 8.08 (SD = 2.43, maximum score 13) 
for nurses and 8.75 (SD = 2.58, maximum score 13) for 
physicians.
Professional social context. Responses relating to the profes-
sional context are listed in Table 3. The mean score for the 
common items was 12.21 (SD = 3.53, maximum score 17) 
for nurses and 13.03 (SD = 3.79, maximum score 17) for 
physicians.
Health system context. Responses to the health system items 
are listed in Table 4. The mean score for the common items 
was 10.50 (SD = 2.59, maximum score 12) for nurses and 
9.29 (SD = 2.39, maximum score 12) for physicians.
Personal and hospital characteristics associated 
with attitude score
A multivariable linear regression was used to identify whether 
participant and hospital characteristics were associated with 
attitude score for the 191 participants with complete data on 
all survey items. This model explained 25% of the variation. 
The internal consistency of the eight items constituting the 
attitude score was acceptable (Cronbach’s α = 0.7). An 
exploratory factor analysis (principal factor method) using 
only these items found evidence for only one domain (eigen-
values for the factors were <1) and the items in the domain 
explained 93% of the variance of that domain. ED physicians 
reported a significantly less positive attitude towards tPA 
treatment than nurses (coefficient = –1.6, 95% CI = (–2.3, 
–1.0)), whereas SCU physicians reported a slightly more pos-
itive attitude than nurses (coefficient = 0.59, 95% CI = (0.01, 
1.18)). Older clinicians were slightly more positive in attitude 
towards tPA treatment (coefficient = 0.03, 95% CI = (0.01, 
0.06)). All other predictors were non-significant (see 
Table 5). A multivariable linear regression including SCU 
and ED physicians indicated that physicians who reported a 
higher proportion of patients being treated with tPA also had 
a slightly (although non-significant) more positive attitude 
towards tPA treatment (coefficient = 0.73, 95% CI = (–0.074, 
1.53), p = 0.075) than other physicians.
Correlation between the actual proportion of 
patients thrombolysed and staff attitude towards 
tPA treatment
At baseline, one of the hospitals had a zero thrombolysis 
rate, eight hospitals had rates between 0% and 4%, eight 
hospitals had rates between 4% and 10% and two hospitals 
Table 1. Participant characteristics.
Characteristics Nurse (n = 355) SCU physician (n = 85) ED physician (n = 63) Combined (n = 503) (%)
Gender
 Male 57 (0.17) 60 (0.72) 44 (0.73) 161 (0.33)
 Female 286 (0.83) 23 (0.28) 16 (0.27) 325 (0.67)
Age (years) Mean = 40 (SD = 11.18)
 <45 223 (0.625) 41 (0.48) 31 (0.49)  
 45–60 90 (0.25) 24 (0.28) 25 (0.40)  
 >60 42 (0.12) 20 (0.24) 7 (0.11)  
Years worked in emergency/stroke
 ⩽5 141 (0.41) 18 (0.22) 10 (0.16) 169 (0.35)
 5–10 111 (0.33) 18 (0.22) 13 (0.21) 142 (0.29)
 11–15 41 (0.12) 14 (0.17) 17 (0.28) 72 (0.15)
 ⩾16 47 (0.14) 33 (0.40) 21 (0.34) 101 (0.21)
Principal rolea
 Emergency physician 1 (0.012) 47 (0.78)  
 Neurologist 42 (0.51)  
 Other physician 40 (0.48) 13 (0.22)  
 Registered nurse 253 (0.52)  
 Enrolled nurse 14 (0.029)  
 Emergency nurse specialist 22 (0.045)  
 Stroke nurse specialist 10 (0.021)  
 Other nurse 90 (0.18)  
SCU: stroke care unit; ED: emergency department.
Some clinical roles have missing data.
aNurses could select multiple roles.
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had rates between 10% and 15% of stroke cases. A non-
significant positive correlation (Spearman = 0.117, p = 0.64; 
Pearson = –0.09, p > 0.05) was found between the actual pro-
portion of patients thrombolysed and staff attitudes towards 
thrombolysis (see Figure 1, Supplementary Material).
Discussion
Although stroke thrombolysis has been an approved and 
guideline-recommended treatment for eligible ischaemic 
stroke patients in Australia since 2003, thrombolysis rates 
remain low. This study provides some insights regarding in-
hospital staff-related reasons as to why Intra Venous 
Thrombolysis rates remain low in Australia and challenges 
associated with achieving improved implementation.
Few staff indicated deficits in technical competencies 
such as being able to accurately identify those eligible for 
tPA (17%) or confidently interpret brain imaging (17% of 
physicians). Given the moderate study response rate, it is 
conceivable that staff with lower competence or confidence 
may have avoided the survey. Therefore, there is potential 
benefit from further decision-making training relating to 
thrombolysis. Less than two-thirds endorsed receiving inter-
active or competency-based training. The majority of physi-
cians (63%) had not participated in competency-based 
assessment for acute stroke protocols, although 98% could 
accurately identify stroke patients, including those eligible 
for tPA (83%). Interactive and competency-based approaches 
may enhance staff ability to confidently make decisions 
regarding challenging cases,38 with greater access to training 
potentially optimising staff competence and confidence in 
stroke care.
There was strong support for tPA as an evidence-based 
treatment. Over 90% of participants supported items regarding 
Table 2. Individual health care provider context and attitudes to acute stroke care.
Variables Agree/strongly agree (n = 503)a (%)
Common skills and experience
 I can accurately identify:
  Stroke patients 483 (0.98)
  Stroke patients eligible for tPA 392 (0.83)
 I have undergone competency-based assessment for stroke protocol 172 (0.37)
 Implementation is limited due to:
  Difficulties using SITSb 120 (0.39)
  Higher intracranial haemorrhage rates in practice 159 (0.40)
Attitudes
 Increasing use of tPA will:  
  Improve odds of independent survival 457 (0.95)
  Increase number with complications/poor outcomesc 201 (0.42)
 Evidence underpinning tPA:
  Is strong when administered within 3 h 427 (0.91)
  Is strong when administered within 4.5 h 349 (0.76)
  Benefits outweigh risks 439 (0.92)
  Has methodological flawsc 178 (0.44)
  Is based on high-quality meta-analyses 317 (0.80)
  Shows theoretical benefit but is hard to achieve 176 (0.42)
Nurse-specific skills and experience
 I regularly care for acute stroke patients 297 (0.86)
 I have received interactive training in best practice stroke care 196 (0.59)
Physician-specific skills and experience
 I can confidently interpret brain imaging scan 118 (0.83)
 I have administered tPA on multiple occasions 87 (0.62)
 I received interactive training in tPA administration 51 (0.37)
 I have undergone competency-based assessment for tPA 27 (0.20)
 I have concerns surrounding:
  Legal implications of tPA 57 (0.40)
  Patient complications of tPA 84 (0.58)
 I regularly have the opportunity to develop skills in stroke imaging (0.69)
tPA: tissue plasminogen activator.
aNumber of respondents who completed that item.
bRefers to difficulties using the data extracted from the Safe Implementation of Thrombolysis in Stroke tool for monitoring thrombolysis care outcomes.
cReverse scoring.
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improving odds of independent survival, strength of evi-
dence when administered within 3 h (91%) and evidence that 
the benefits outweigh the risks (92%). However, 42% to 58% 
of participants agreeing with statements regarding evidence-
based limitations and risk of patient complications is telling. 
For example, 42% reported that increasing thrombolysis 
rates would increase rates of poor outcomes, and 42% 
reported that benefit was difficult to achieve in practice. As 
negative outcomes often receive significant attention, staff at 
the early stage of thrombolysis implementation may be par-
ticularly influenced by cases with poor outcomes, possibly 
resulting in reduced treatment of further cases. The opportu-
nity to discuss the evidence base for thrombolysis with more 
experienced stroke physicians and obtain timely expert 
review of all cases may be especially valuable for early-stage 
stroke thrombolysis teams.
Most participants responded favourably to questions 
regarding the professional context of stroke thrombolysis at 
their hospital, with more than 80% agreement with leader-
ship and supervision items, with the exception of personal 
performance monitoring (75% agreement). Workplace 
culture and practice opportunities appeared positive, 
although only 35% reported regular performance feedback, 
51% reported individual performance goals for stroke and 
68% of nurses reported opportunities to develop stroke care 
skills.
System-related responses were generally positive, with 
more than 80% agreement with items regarding appropriate 
policies and processes. The less positive aspects were as fol-
lows: availability of checklists or decision aids (78% agree-
ment), diversion of eligible patients to appropriate hospitals 
(63%) and capacity to make beds available quickly (65%). 
The latter two are likely to be a hindrance, given the time 
urgency surrounding this treatment.
Although there was a positive correlation between atti-
tude score and thrombolysis rates, this association was not 
significant. The study had limited power due to the relatively 
small number of sites and relatively little variability in aver-
age attitude scores between sites (11% power to detect a cor-
relation of 0.1 at 5%).
Stroke care physicians were more positive than nurses and 
it was clear that emergency physicians were not positive 
Table 3. Professional social context.
Variables Agree/strongly agree (n = 503)a (%)
Leadership and supervision
 Respected staff:
  Advocate for tPA use 440 (0.93)
  Actively demonstrate best practice 432 (0.91)
  Monitor my performance of stroke care 343 (0.75)
  Monitor hospitals’ performance on key stroke care 418 (0.90)
  Monitor actions which are inconsistent with guideline 374 (0.82)
  Monitor proportion of eligible stroke patients who receive tPA 392 (0.88)
 At all times I have immediate access to advice:
  From senior colleague in stroke managementb 109 (0.81)
  By a senior colleague in care provision 413 (0.86)
Workplace culture and opportunity
 I am regularly given individual performance feedback following acute stroke cases 163 (0.35)
 Hospital regularly receives feedback on performance on stroke care indicators 249 (0.62)
 If I do not follow stroke care protocol, there are negative consequences for:
  Patient 425 (0.90)
  Hospital 368 (0.81)
  Me 355 (0.78)
 I regularly treat acute stroke patients 133 (0.92)
 I regularly have opportunity to:
  Treat stroke cases of varying complexity 133 (0.92)
  Care for stroke cases of varying complexity 421 (0.86)
  All times I have immediate access to brain imaging facilities and staff trained to 
interpret those images
378 (0.79)
 I have individual performance goals related to stroke care 238 (0.51)
Nurse specific
 I have seen tPA administered on multiple occasions 168 (0.52)
 I regularly have opportunity to develop skills in stroke care 235 (0.68)
tPA: tissue plasminogen activator.
aNumber of respondents who completed that item.
bPhysician only item.
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about thrombolysis, as has been reported elsewhere.37 
Emergency physician attitudes are reflected in the Australian 
College for Emergency Medicine commissioning a review39 
of the evidence for IV thrombolysis to guide a national 
position statement.40 Future studies may identify whether this 
difference relates to perceptions about the evidence or is a 
result of patient experiences. Given that emergency and 
stroke physicians thrombolysing more patients had more pos-
itive attitudes towards the treatment, older clinicians were 
more positive than younger clinicians and that performance 
Table 4. Health system context.
Variables Agree/strongly agree (n = 503) (%)
Hospital policy for:
 Management and care of stroke 468 (0.96)
 Rapid referral to stroke specialists 425 (0.89)
Emergency/ambulance services:
 Quickly and correctly identify stroke patients 401 (0.88)
 Use recognised tool for identifying stroke patients 391 (0.89)
 Follow procedures for early notification of stroke patient 373 (0.84)
 Routinely divert stroke patients to thrombolysis hospitals 253 (0.63)
Hospital policy
 Rapid access to imaging 451 (0.93)
 Administration of tPA 447 (0.93)
Hospital has:
 Quality indicators 442 (0.92)
 Performance goals 423 (0.90)
Checklists/decision aids to help:
 Order and interpret imaging 113 (0.78)
 Identify stroke patients eligible 377 (0.85)
Hospital has capacity and system to make bed available quicklya 221 (0.65)
Checklists/decision aids help me identify and triage stroke casesa 278 (0.91)
tPA: tissue plasminogen activator.
aNurse-only item.
Table 5. Attitude scores.
Characteristics Parameter estimate (95% Wald CI) p valuea (%)
Staff role
 ED –1.6 (–2.3, –1.0) <.001
 SCU 0.59 (0.01, 1.18)  
 Nurse Referent  
Gender
 Male –0.19 (–0.66, 0.28) 0.423
 Female Referent  
Age (years) 0.03 (0.01, 0.06) 0.009
Years worked in emergency/stroke
 ⩽5 Referent 0.402
 5–10 –0.20 (–0.80, 0.40)  
 11–15 –0.59 (–1.28, 0.10)  
 ⩾16 –0.41 (–1.18, 0.36)  
Estimated number of ischaemic patients seen by ED every fortnight
 100-unit increase 0.29 (–1.8, 2.42) 0.789
Estimated proportion of eligible ischaemic stroke patients treated –0.13 (–0.73, 0.47) 0.676
Hospital type
 Regional 0.08 (–0.40, 0.56) 0.741
 Metro Referent  
CI: confidence interval; ED: emergency department; SCU: stroke care unit.
Multivariable linear regression with attitude score as the outcome including variables common to all staff types as predictors (n = 191, R2 = 25.3%).
aThe p values are from F tests assessing reduction in error sums of squares due to adding variable to the model that includes all other variables.
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feedback was generally not included in the training or moni-
toring that participants received, it is important to clarify how 
the evidence and personal experience interact to influence 
practice.
Limitations
It is possible that those with an interest in stroke thrombolysis 
were more likely to respond to the survey; thus, study results 
may present a slightly more positive picture of the per ceptions 
regarding stroke thrombolysis. The psychometric properties 
of the survey have not been tested; therefore, it is possible 
that there may be potential for bias or inaccuracy. The high 
proportion of missing data limited the ability of the study to 
examine characteristics associated with attitude scores. There 
was no evident pattern to which the participants answered 
any particular items and no particular item was found to have 
a relatively high rate of missing data; therefore, this may limit 
the generalisability of the secondary aims.
Conclusion
Australian hospitals seeking to address barriers to stroke 
thrombolysis implementation may benefit from the availabil-
ity of interactive and competency-based training, staff perfor-
mance feedback, support to make beds available quickly and 
bypass arrangements to quickly deliver acute stroke patients 
to appropriate facilities. Given the survey response rate, there 
is also a need to further explore staff interpretation of the evi-
dence and their stroke thrombolysis experience.
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